Download ebook: Your Patent Expiry Update – 2014 and beyond

Patent expiry has increasingly proved problematic for the Pharma industry. Whilst blockbuster drugs lose their patent protection and companies suffer losses in brand spending, generics steal the market with cheap, accessible, copycat alternatives.  While products worth $66 billion will lose protection in 2015, companies grasp on to their patents insisting they promise innovation and aid invention. The debate over the …

Europe, US, Transatlantic, Trade, Investment, Agreement, Generics

EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry

At the World Generic Medicines Congress Europe 2014, Michel Mikail, Fresenius Kabi, gave a presentation on “EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry”. Download and learn: EU-US Transatlantic Trade & Investment Partnership (TTIP) Intellectual Property Rights Other ongoing negotiations FTAs’ opportunities and challenges Download presentation  Found this interesting? Join us at the 9th annual World Generic Medicines Congress Europe, …

capitalizing, growth opportunities, complex generics, business models

Capitalizing On Growth Opportunities For Complex Generics To Strengthen Business Models

At the World Generic Medicines Congress Europe 2014, Dr Deepak Murpani, Synthon, gave the presentation “Capitalizing On Growth Opportunities For Complex Generics To Strengthen Business Models ” Download and learn: Why generics/ complex generics? Market trend What are complex generics? Case studies Summary Download presentation Found this interesting? Join us at the 9th annual World Generic Medicines Congress Europe, happening this 4-5 …

BioPharma México es donde reunen expertos cómo Industrias Químico Farmacéuticas Americanas para relacionarse, aprender del otro, y discutir los desarrollos más recientes de la industria biofarmacéutica mexicana.

Industrias Químico Farmacéuticas Americanas en los Medicamentos Genéricos

Walter Westphal es el CEO de Laboratorio Industrias Químico Farmacéuticas Americanas S.A. de C.V. Cursó los estudios de maestría en la Universidad La Salle de México y recibió un diplomado en Manejo de Alimentos Industriales de la Universidad del Sur de California en Los Ángeles. Cuenta con vasta experiencia en el manejo estratégico y planeación de crecimiento, optimización de cadena …

competitive, generics, market

Small is beautiful: Winning in the highly competitive generics market

At the World Generic Medicines Congress Europe 2014, John Beighton, CEO,  Amdipharm Mercury Company Ltd gave a presentation on “Small is beautiful: Winning in the highly competitive generics market” Beighton’s presentation explores an entrepreneur’s dilemma of “How to grow without losing the “spirit” of what creates value” Download and learn: Strategic Growth Background: The In-market value chain Global Coverage Five Distinct go-to-market approaches for …

GaBi Journal partners with Total Biopharma, in association with the World Biosimilar Congress, Nov 2014

Guest Post: GaBI – Building trust in cost-effective treatments

A frequent partner of our Life Science conferences, GaBI Journal is an independent and peer reviewed academic journal, encompassing all aspects of generic and biosimilar medicines development and use, from fundamental research up to clinical application and policies. View the latest issue of GaBI Journal to learn about pharmaceutical innovation and developments in generic and biosimilar medicines. Volume 3, 2014, Issue …

Dr Reddy’s launches antibiotic drug in US market

Dr Reddy’s Laboratories has launched Moxifloxacin Hydrochloride tablets in the US market for the treatment of diseases including pneumonia, bronchitis and skin infections. It was approved by the United States Food and Drug Administration, amidst the tightened regulations by the FDA on Indian exports. The tablets are a generic version of Avelox. Bayer’s Avelox is for the treatment of community …

Sanofi files cases against Glenmark on patent infringement

Sanofi filed a patent infringement petition against Glenmark on their cardiac drug Multaq in the district court of Delaware. They filed the suit against Glenmark and Actavis wanting to prevent them from commercializing its ANDA productprior to the expiration of certain US patents. Multaq is an anti-arrhythmic drug that reduces the risk of hospitalisation for atrial fibrillation (AF) in patients …

India’s Lupin queues up for a share of the biosimilar boom

Lupin is searching for partners to help bring it into the biosimilars market, aiming top-selling treatments with patents that are expiring soon. It already has 10 biosimilars products in development, with 5 in late-stage studies. Thus, it is looking for partners to help bring these products into the market. In addition to injectables for cancer and inflammatory disease, Lupin is …

Download ebook: Top challenges and opportunities in generic medicines

  The benefits of generic medicines are well celebrated and they play an important role in treating disease by increasing the accessibility and affordability. Generics are a key contributor in securing sustainable health care systems but long term sustainability relies on fair price and a level playing field. In the current challenging market there are a number of hurdles to …